OPTIMUM Study of Remote Patient Monitoring in Ambulatory Heart Failure Care
OPTIMUM
OPTIMUM: OPTIMisation du Parcours de Soins du Patient Insuffisant Cardiaque Chronique
1 other identifier
observational
504
1 country
1
Brief Summary
Heart failure is a leading cause of hospitalization and readmission, particularly among older adults with multiple comorbidities. Traditional outpatient follow-up may be insufficient to detect early clinical deterioration in this vulnerable population. Remote patient monitoring (RPM) using non-invasive symptom and weight tracking has been proposed to enhance ambulatory care, but its effectiveness appears to depend on integration within structured care pathways. The OPTIMUM study evaluated the real-world implementation of an integrated ambulatory heart failure care pathway combining non-invasive RPM with multidisciplinary follow-up in routine clinical practice. Patients enrolled after a recent heart failure hospitalization were managed using the Satelia® Cardio monitoring system, nurse-led therapeutic education, and a planned cardio-geriatric day-hospital reassessment. The study aimed to describe pathway implementation and assess associations with rehospitalizations, mortality, alert activity, and patient and healthcare professional satisfaction in an older, frail population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedFirst Submitted
Initial submission to the registry
February 6, 2026
CompletedFirst Posted
Study publicly available on registry
February 27, 2026
CompletedFebruary 27, 2026
February 1, 2026
2.5 years
February 6, 2026
February 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Cardiac Rehospitalizations
Total number of hospital admissions with a primary cardiac diagnosis (ICD-10 codes I50.x) occurring during the 12 months following enrollment in the ambulatory care pathway, compared descriptively with the 12 months preceding enrollment.
1 year before enrollment and 1 year after enrollment
Secondary Outcomes (5)
All-Cause Hospitalizations
1 year before enrollment and 1 year after enrollment
All-Cause Mortality
Up to 24 months after enrollment
Cardiovascular Mortality
Up to 24 months after enrollment
Remote Patient Monitoring Alert Activity
1 year
Patient and Healthcare Professional Satisfaction with the Care Pathway
At the end of follow up or the study period
Study Arms (1)
Integrated Ambulatory Heart Failure Care Pathway
Patients with a recent hospitalization for acute heart failure (or prior hospitalization within 12 months) who were enrolled in a structured ambulatory care pathway in routine clinical practice. The pathway included non-invasive remote patient monitoring, nurse-led therapeutic education, and a planned multidisciplinary cardio-geriatric outpatient reassessment.
Interventions
A non-invasive remote patient monitoring system based on regular patient-reported symptom questionnaires and body weight measurements. A built-in algorithm generates color-coded alerts (green, orange, red) to support early detection of potential heart failure decompensation. Alerts are reviewed by healthcare professionals as part of routine care.
Eligibility Criteria
The study population consisted of adults with heart failure managed in routine clinical practice at a tertiary care center in Lyon, France. Most participants were enrolled following a recent hospitalization for acute heart failure, while a smaller proportion were included after outpatient evaluation with a history of heart-failure hospitalization within the prior 12 months. The population was predominantly older and medically complex, with a high burden of comorbidities, polypharmacy, and functional vulnerability. Many participants met criteria for frailty and had limitations that could affect self-management, such as mobility impairment, sensory deficits, or cognitive difficulties. Despite this, the majority were living at home at the time of enrollment, often with support from caregivers or community services.This cohort reflects a real-world ambulatory heart failure population at high risk of rehospitalization and functional decline, representative of older patients commonly encoun
You may qualify if:
- Age ≥18 years
- Diagnosis of heart failure
- Hospitalization for acute heart failure or a cardiac cause OR outpatient evaluation with a history of heart-failure hospitalization within the previous 12 months
- Enrollment into the OPTIMUM ambulatory heart failure care pathway
- Ability to provide informed consent
- Agreement to participate in remote patient monitoring
You may not qualify if:
- Inability to provide informed consent
- Refusal to participate in remote patient monitoring or the OPTIMUM care pathway
- Physical, cognitive, or psychological limitations incompatible with use of the remote monitoring system
- Treating clinician judged that adherence to telemonitoring would be insufficient
- Presence of a non-cardiac comorbidity associated with an estimated life expectancy of less than 12 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Médipôle Hôpital Mutualiste
Lyon, Auvergne-Rhône-Alpes, 69100, France
Related Publications (4)
Aleyan M, Paradisi-Prieur L, Nisse-Durgeat S, et al. Annales de Cardiologie et d'Angéiologie, Volume 72 - Issue 5, November 2023, 101649. doi: 10.1016/j.ancard.2023.101649
BACKGROUNDJourdain P, Pages N, Amara W, Maribas P, Lafitte S, Lemieux H, Barritault F, Seronde MF, Labarre JP, Chaouky H, Bedel C, Betito L, Nisse-Durgeat S, Picard F. Perceptions and satisfaction of patients with chronic heart failure when using a remote monitoring web application named Satelia(R) Cardio. Ann Cardiol Angeiol (Paris). 2023 Jun;72(3):101606. doi: 10.1016/j.ancard.2023.101606. Epub 2023 May 25. French.
PMID: 37244215BACKGROUNDGirerd N, Barbet V, Seronde MF, Benchimol H, Jagu A, Tartiere JM, Hanon O, Picard F, Lafitte S, Lemaitre M, Pages N, Nisse-Durgeat S, Jourdain P. Association of a remote monitoring programme with all-cause mortality and hospitalizations in patients with heart failure: National-scale, real-world evidence from a 3-year propensity score analysis of the TELESAT-HF study. Eur J Heart Fail. 2025 Sep;27(9):1658-1669. doi: 10.1002/ejhf.3563. Epub 2025 Jan 14.
PMID: 39807086BACKGROUNDPages N, Picard F, Barritault F, Amara W, Lafitte S, Maribas P, Abassade P, Labarre JP, Boulestreau R, Chaouky H, Abdennadher M, Lemieux H, Lasserre R, Bedel C, Betito L, Nisse-Durgeat S, Diebold B. Remote patient monitoring for chronic heart failure in France: When an innovative funding program (ETAPES) meets an innovative solution (Satelia(R) Cardio). Digit Health. 2022 Aug 22;8:20552076221116774. doi: 10.1177/20552076221116774. eCollection 2022 Jan-Dec.
PMID: 36034602BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mehdi Aleyan, MD
Department of Cardiology, Médipôle Hôpital Mutualiste
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2026
First Posted
February 27, 2026
Study Start
January 1, 2021
Primary Completion
July 1, 2023
Study Completion
July 1, 2025
Last Updated
February 27, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be made publicly available because the dataset contains sensitive health information from a small, single-center cohort, which could increase the risk of participant re-identification despite de-identification procedures. Data were collected as part of routine clinical care and are subject to French and European data protection regulations (GDPR). Aggregated results are reported in study publications.